A hybridization assay procedure was devised that makes possible quantitation of the ratio of mRNA of alpha to mRNA of beta globin chains in an RNA sample. The assay uses the radioactive synthetic DNA copies obtained by incubation of RNA-dependent DNA polymerase of avian myeloblastosis virus with rabbit globin mRNA that is 80-90%4 enriched in mRNA specific for synthesis of alpha or beta globin chains. The rabbit alpha-chain mRNA is obtained from the postribosomal supernatant of rabbit reticulocyte lysates; the rabbit beta-chain mRNA is obtained from the largest polysomes of rabbit reticulocytes treated with L-O-methylthreonine. Sufficient homology exists between rabbit and human globin chains and globin mRNAs that the synthetic DNA copies of chainspecific rabbit globin mRNA hybridize with human globin mRNA. Applied to the study of globin mRNA isolated from reticulocytes of humans with alpha and beta thalassemia, the technique revealed marked quantitative deficiency of alpha-chain mRNA relative to beta-chain mRNA in alpha thalassemia and similar deficiency of beta-chain mRNA relative to alpha-chain mRNA in beta thalassemia. The thalassemia' syndromes are therefore characterized by true quantitative deficiency of the mRNA specific for the affected globin chain.
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The thalassemia syndromes are inherited disorders of hemoglobin (Hb) synthesis characterized by absent or decreased synthesis of alpha (a) or beta (f) globin chains of human adult hemoglobin (1) (2) (3) (4) (5) . When there is some synthesis of the affected globin chain, analysis of its peptides reveals no evidence of an aminoacid substitution (6) (7) (8) , nor is there evidence of synthesis of incomplete globin chains where there is total absence of the globin chain (9) . There is a great deal of evidence, however, that the genes for a and f thalassemia are closely linked to the genes for the structural loci of the a and f globin chains, respectively (1) .
Studies on various aspects of Iolypeptide chain initiation and translation in homozygous f thalassemia have revealed no abnormalities (10) (11) (12) (13) (14) (15) . However, when globin mRNA isolated from fi thalassemia reticulocytes is added to a heterologous cell-free system, much less human fi chain is synthesized than a chain (16) (17) (18) . The opposite is observed in the a thalassemia syndrome of Hb H disease (19, 20 there exists in these conditions a normal amount of a structurally and functionally abnormal mRNA. Recent studies in ,3 thalassemia of the Ferrara type, in which there is a total absence of fl-chain synthesis (beta0 thalassemia), suggest that strict deficiency of mRNA may not be the only factor involved in that type of fl thalassemia because, in a cell-free system, the addition of ribosome-free supernatant fraction, from reticulocytes of nonthalassemic patients containing Hb A or Hb S, to ribosomes of these patients with beta0 thalassemia, leads to the synthesis of some betaA, but not betas, globin chain (21, 22) .
Our approach to the problem has been to devise specific assays for a-and f-chain mRNA that do not depend on the ability of the RNA to function as messenger. It is possible to synthesize a radioactive DNA copy of globin mRNA (cDNA) by using the RNA dependent-DNA polymerase of avian myeloblastosis virus (23) (24) (25) . This DNA can be used in DNA-RNA hybridization assays to identify and quantitate globin mRNA in an RNA sample. Furthermore, it is possible to isolate rabbit globin mRNA that is 80-90% pure for a (26) or fi (27) globin mRNA activity when translated in a cell-free system. DNA synthesized from such chain-specific mRNA can be used to quantitate the ratio of a to fi mRNA in a given preparation of rabbit globin mRNA (D. Housman, A. Skoultchi, & G. Temple, manuscript submitted). We have extended these methods to the study of human globin mRNA. Because there is sufficient cross-hybridization between human globin mRNA and rabbit globin cDNA (24, 25) , we have been able to use the chain-specific rabbit globin cDNAs to quantitate the ratio of a to fi globin mRNA in the reticulocyte RNA of humans with different thalassemia syndromes.
Our results indicate that in the a thalassemia syndrome of Hb H disease the a/fl mRNA ratio is 1: 6, whereas in homozygous fl thalassemia the a/f mRNA ratio is 10 Preparation of Human and Rabbit Globin mRNA. Rabbit globin mRNA was obtained as described (27) . Globin mRNA enriched for rabbit (3-chain mRNA was isolated from the largest polysomes of reticulocytes treated with L-O-methylthreonine (27) and was the gift of G. Temple. Globin mRNA enriched for rabbit a-chain mRNA was isolated from ribosomefree, reticulocyte lysate supernatant fraction (26) and was the gift of Mr. H. Meade and Dr. C. Baglioni. The chain-specific rabbit mRNAs were purified by repeated sucrose gradient centrifugations until they yielded a single RNA peak with a sedimentation coefficient of 10 S. Translation of the mRNAs in the cell-free system of Krebs II mouse ascites tumor showed them to be about 90% pure for a or (3 mRNA activity.
Human reticulocyte RNA was prepared by phenol-cresol extraction of membrane-free reticulocyte lysates (17) , and the total cellular RNA was fractionated by sucrose gradient centrifugation. The RNA sedimenting between 4 and 18 S was precipitated and served as the partially purified human globin mRNA samples used for cell-free synthesis, hybridization to cDNA, and synthesis of human cDNA. The amount of 1OS globin mRNA in such human mRNA samples was quantitated by acrylamide gel electrophoresis of the RNA and scanning of the unstained gels at A260 (17) ; the 10S RNA was usually 25-30% of the total RNA in the sample, and the amount of RNA used in the hybridization experiments shown in Figs. 2 and 3 refer to 10S RNA, not total RNA. 1 ,ug of RNA was considered to be equivalent to 0.025 A260 units.
Synthesis of Radioactive DNA Copy of Globin mRNA. Singlestranded DNA copies of high specific radioactivity were obtained by incubation of the mRNAs with partially purified RNA-dependent DNA polymerase of avain myeloblastosis virus, oligo(dT)12_16, [3H]dGTP, and actinomycin D (23).
The DNA product was incubated at 370 for 18 hr in 0.3 N KOH, then neutralized with HCL. E. coli tRNA (50 ,g) was added as carrier. The DNA was isolated by Sephadex G-150 gel filtration in 0.1 M ammonium bicarbonate buffer, lyophilized, and resuspended in H20. The cDNA obtained from partially purified (nonthalassemic) human globin mRNA and that obtained from the single 1OS RNA band isolated by acrylamide gel electrophoresis of the same human mRNA, were used as templates for synthesis of 32P-labeled RNA by E. coli RNA polymerase. Identical fingerprint patterns were obtained from the [32P]RNA copies of both types of cDNA, and the nucleotide sequences of most of the oligonucleotides match known aminoacid sequences in either a or 3 globin chains (32) . Furthermore, the RNA transcript from the a thalassemia cDNA used in the experiments to be presented below yields a similar fingerprint pattern, but with definite quantitative differences between the oligonucleotides: one very prominent set and one very faint set of oligonucleotides. The sequences present in the prominent oligonucleotides match (3-chain, but not a-chain, aminoacid sequences (32) .
Hybridization Assays contained in 5 ul, 0.2 M sodium phosphate buffer (pH 6.8), 0.5% sodium dodecyl sulfate, 100 sealed capillary tubes. The amount of labeled DNA hybridized was determined by diluting the reaction mixture into 2 ml of a solution containing 0.1 M sodium acetate (pH 4.5), 1 mM ZnSO4, 10 Ag/ml of calf-thymus DNA (heat-denatured), and sufficient Aspergillus oryzae S1 nuclease to digest denatured 3H-labeled DNA of bacteriophage P22 so that less than 5% of its cpm remained acid-precipitable, while no more than 5% acid-soluble counts were released from the native (double-stranded) phage DNA; incubation was for 30 min at 45°. The remaining nuclease-resistant trichloroacetic acidprecipitable counts (less the counts in a similarly processed blank containing cDNA but no RNA) were taken to represent the specific hybrid; percent hybridization was calculated in reference to the acid-precipitable counts in a similarly incubated but nondigested blank reaction mixture containing cDNA but no RNA. (Fig. 1) gives an a mRNA to (3 mRNA content of about 8/1 for the rabbit a mRNA preparation and 1/6 for the rabbit (3 
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The conditions were the same in (A), except that the temperature was 78°. The cDNA input was 211 cpm per reaction mixture over a background of 19 cpm; the digested blank reaction mixture without mRNA contained 0 cpm above background. a mRNA preparation, for example, this half-saturation value corresponds to 2.5 ng in hybridization against rabbit fi cDNA, and 0.3 ng in hybridization against rabbit a cDNA; for the rabbit (3 mRNA preparation, these values are 0.5 ng and 3 ng, respectively. The ratio of these values is a direct measure of the ratio of a to ( mRNA sequences in these RNA preparations, and indicate that the a mRNA has (3 mRNA in it to the extent of 12% and that the (3 mRNA has a mRNA in it to the extent of 16%. This procedure is used for determining the ratio of a to (3 mRNA sequences in each RNA preparation considered below.
Hybridization of Human Globin mRNA to Chain-Specific Rabbit cDNA. Hybridization of total (or mixed) human globin mRNA to rabbit a-and f-chain-specific cDNA is shown in Fig. 2 . With both cDNAs, half-saturation of hybridization is obtained with about the same amount of RNA (0.2-0.25 ng). This result indicates that the relative amounts of a and (3 mRNA in the human RNA are about equal. The maximum amount of hydridization or percent hybridization of human mRNA is higher with rabbit a cDNA (70-80%) than with rabbit (3 cDNA (40%). This difference in percent hybridization of human RNA with the different rabbit cDNAs could be due to several factors. One possible explanation is that Proc. Nat. Acad. Sci. USA 70 (1978) 4 --I differences in the third or "wobble" position of each codon may be much more frequent in 3 mRNA sequences between human and rabbit than they are in the a mRNA sequences.
Hybridization of a-Thalassemia mRNA with Chain-Specific Rabbit cDNA. The results of hybridization obtained with reticulocyte mRNA from a patient with a thalassemia (Hb H disease) are shown in Fig. 2 . The ratio of a/f mRNA sequences determined by half-saturation values of the RNA against fi cDNA (0.5 ng) and a cDNA (2.9 ng) is roughly 1/6 and indicates a marked deficiency of a mRNA relative to fi mRNA in the a-thalassemia RNA. Since the sample includes RNA from a whole-cell lysate rather than a polysome preparation, these results rule out the presence of a significant amount of functionally deficient a-chain mRNA that is unable to enter polysomes.
Although the a//3 globin chain synthetic ratio of this patient's intact reticulocytes was 1/3 (data not shown), the mRNA isolated from these reticulocytes showed a much more profound deficiency of a mRNA activity, when translated in the cell-free system of Krebs II mouse ascites tumor (19) : the a/f globin chain synthetic ratio in the cell-free system was 1/25 (data not shown). The a/fl mRNA ratio obtained by hybridization gives an intermediate value between these two extremes. In a second unrelated patient with Hb H disease, similar hybridization anid intact-cell and cell-free globin synthesis results were obtained. Discrepancy between intact-cell and cell-free mRNA-directed protein synthesis in a thalassemia has also been reported by others (20) . All of these findings may indicate the presence, in the a-thalassemia reticulocyte, of interchain protein synthesis regulation, and translational depression of f-chain synthesis or release, due to the absence of a chains. A role of a chains in the regulation of f-chain synthesis has been suggested (33) (34) (35) (36) (37) .
Hybridization of f-Thalassemia mRNA with Chain-Specific
Rabbit cDNA. The fi-thalassemia mRNA shows the same pattern of hybridization with rabbit a cDNA as the normal human mRNA ( Fig. 2A) : half-saturation of hybridization is achieved with 0.25 ng of RNA. Hybridization of the ,B-thalassemia mRNA with rabbit fi cDNA revealed half-saturation of hydridization achieved with 0.5 ng of RNA (Fig. 2B) .
These results indicate the presence of only twice as much a as non-a mRNA in the fi-thalassemia mRNA. In the cell-free system this same mRNA promotes the synthesis of only 1/10 as much ,B chain as a chain, but it also promotes the synthesis of significant amounts of the y chain of fetal hemoglobin which is usually increased in fi thalassemia. There is about half as much -y-as a-chain synthesis in the cell-free system, whereas there is 1/3 as much y-as a-chain synthesis in the patient's intact reticulocytes (data not shown). Because there is a good deal of homology between the human y and ,B globin chains (39 amino acids different out of 146), the human -y mRNA present in the sample could be hybridizing with the rabbit ,B cDNA and giving a falsely high value for fi mRNA content in the sample. For this reason a more specific test for quantitation of human fi mRNA was devised.
Hybridization of Human mRNA with Human f cDNA. Two major variables were altered to permit quantitation of ,B mRNA (relative to a mRNA) in the presence of an excess of hybridization mixture. Secondly, the hybridization temperature was increased from 650 to 780 in order to render less stable any -y mRNA-,B cDNA hybrids.
To obtain cDNA containing predominantly sequences complementary to human fl-chain mRNA, we took advantage of our previous demonstration of marked a-chain mRNA deficiency in a-thalassemia mRNA. Fingerprint analysis of the RNA copy synthesized from this cDNA bears out the contention that this cDNA contains predominantly fl-chain sequences.
Initial hybridization experiments were done at 650. The results are shown in Fig. 3A . With the normal (nonthalassemic) human mRNA, half-saturation of hybridization is achieved with the same amount of RNA (0.25 ng) as required to achieve half-saturation of hybridization against the rabbit a cDNA (Fig. 2A) ; this result again indicates about equal amounts of a and B mRNA in normal human RNA.
The a/fl mRNA ratio obtained, by the same calculation, for the f-thalassemia mRNA in this experiment is 4.8/1 (1.2 ng against human cDNA/0.25 ng against rabbit a cDNA). However, the plateau value for fi-thalassemia mRNA hybridized to human cDNA (% hybrid) was lower (50%) than that for the normal human mRNA (80%). This observation suggested the possibility that some of the hybrids formed at 650 were duplexes between -y mRNA and cDNA.
Analysis of the melting profile of the hybrids formed at 650 confirmed that a significant fraction (30%) of the fi-thalassemia mRNA-human cDNA hybrids had a lower melting temperature (800) than the hybrids between normal human mRNA and human cDNA (930) (data not shown). To eliminate this low-melting component, which we believe to be due to hybrids between y-chain mRNA and fl-chain cDNA, we increased the temperature of hybridization to 780. The results of the 780 hybridization are shown in Fig. 3B : no change occurred in the saturation curve of normal (human) mRNA compared to the results obtained at 650. However, the amount of fi-thalassemia mRNA required to reach half-saturation of hybridization was much greater than at 650 (5 ng instead of 1.2 ng). The ratio of a-chain mRNA to f-chain mRNA in the B-thalassemia RNA is therefore about 10:1 (5 ng against human cDNA/0.5 ng against rabbit a cDNA). Again, as the ratio of a to mRNA in total cellular RNA rather than polysomal RNA has been determined, it seems very unlikely that a significant amount of fl-chain mRNA sequences that cannot be translated is present in these cells. DISCUSSION A large amount of experimental evidence has accumulated that indirectly suggests that there must exist a quantitative deficiency in mRNA for one or another globin chain in the various thalassemia syndromes. Even the demonstration that mRNA isolated from thalassemic reticulocytes reproduces, in heterologous cell-free systems, the imbalance of globin-chain synthesis characteristic of intact thalassemic reticulocytes, does not rule out the possibility of a structurally and functionally abnormal mRNA for the affected chain, present in normal amounts within the thalassemic reticulocytes. The results of the hybridization experiments described in this report provide direct evidence for the suspected quantitative deficiency of chain-specific globin mRNA in both a-and fi-thalassemia human -y-chain mRNA. First, human fl-chain [3H ] cDNA was synthesized and replaced rabbit fl-chain cDNA in the Proc. Nat. Acad. Sci. USA 70 (1973) syndromes. This 
